Derek Rapp joined RiverVest in 2019 as managing director. In addition to being involved in RiverVest’s investment process, Rapp works closely with the management team on strategy, operations, fundraising and investor relations. He also serves as RiverVest’s liaison to St. Louis’ growing innovation system.
Formerly president & CEO of JDRF, the world’s largest non-government funder of diabetes research and a major advocacy group for the type 1 diabetes community, Rapp also previously served as CEO for life sciences start-up Divergence, Inc., which he led to a successful exit. He also served as head of mergers and acquisitions at Monsanto where he led transactions totaling more than $6 billion.
“I am thrilled to work with RiverVest’s outstanding team as we continue to make impactful investments in companies that will generate excellent returns and provide solutions to profound human health needs.”
Derek brings to the RiverVest team his broad leadership experience within different facets of healthcare, along with entrepreneurial and strategic skills. He received his M.B.A. from the Wharton School of the University of Pennsylvania and his B.A. from Brown University.